Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-24-006212

Head of Development sold 108 shares at $221.49 ($23,921)

  • Head of Development gave up 468 shares (to pay taxes)
  • Head of Development acquired 1,208 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Singhal Priya · Head of Development

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-16 Exercise or conversion : show line 1 in the form 10b5-1 +819 5,335.09 D
2024-02-16 Shares withheld for taxes : show line 2 in the form 10b5-1 −295 $219.08 $64,629 5,040.09 D
2024-02-16 Exercise or conversion : show line 3 in the form 10b5-1 +389 5,429.09 D
2024-02-16 Shares withheld for taxes : show line 4 in the form 10b5-1 −173 $219.08 $37,901 5,256.09 D
2024-02-16 Sale : show line 5 in the form 10b5-1 −108 $221.49 $23,921 5,148.09 D
Open-market sales · 108 sh · avg $221.49 · $23,921

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-02-16 Exercise or conversion : show line 6 in the form 10b5-1 Performance Stock Unit −819 0 D
2024-02-16 Exercise or conversion : show line 7 in the form 10b5-1 Restricted Stock Unit −389 485 D
2024-02-16 Other disposition : show line 8 in the form 10b5-1 Restricted Stock Unit −485 0 D
Loading xslF345X05/form4.xml…